Search Results - "Burm, Saskia"
-
1
Colony-Stimulating Factor 1 Receptor (CSF1R) Regulates Microglia Density and Distribution, but Not Microglia Differentiation In Vivo
Published in Cell reports (Cambridge) (31-07-2018)“…Microglia are brain-resident macrophages with trophic and phagocytic functions. Dominant loss-of-function mutations in a key microglia regulator,…”
Get full text
Journal Article -
2
VISTA expression by microglia decreases during inflammation and is differentially regulated in CNS diseases
Published in Glia (01-12-2018)“…V‐type immunoglobulin domain‐containing suppressor of T‐cell activation (VISTA) is a negative checkpoint regulator (NCR) involved in inhibition of T…”
Get full text
Journal Article -
3
An Overview of in vitro Methods to Study Microglia
Published in Frontiers in cellular neuroscience (06-08-2018)“…Neuroinflammation is a common feature in neurodegenerative diseases and strategies to modulate neuroinflammatory processes are increasingly considered as…”
Get full text
Journal Article -
4
Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors
Published in Cancer discovery (02-05-2022)“…Checkpoint inhibitors (CPI) have revolutionized the treatment paradigm for advanced solid tumors; however, there remains an opportunity to improve response…”
Get more information
Journal Article -
5
Inflammasome-induced IL-1β secretion in microglia is characterized by delayed kinetics and is only partially dependent on inflammatory caspases
Published in The Journal of neuroscience (14-01-2015)“…Inflammasomes are multiprotein complexes that link pathogen recognition and cellular stress to the processing of the proinflammatory cytokine interleukin-1β…”
Get full text
Journal Article -
6
Transcriptome analysis reveals the contribution of oligodendrocyte and radial glia‐derived cues for maintenance of microglia identity
Published in Glia (01-04-2022)“…Microglia are increasingly being recognized as druggable targets in neurodegenerative disorders, and good in vitro models are crucial to address cell…”
Get full text
Journal Article -
7
An Fc-inert PD-L1×4-1BB bispecific antibody mediates potent anti-tumor immunity in mice by combining checkpoint inhibition and conditional 4-1BB co-stimulation
Published in Oncoimmunology (2022)“…Immune checkpoint inhibitors (ICI) targeting the PD-1/PD-L1 axis have changed the treatment paradigm for advanced solid tumors; however, many patients…”
Get full text
Journal Article -
8
DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity
Published in Journal for immunotherapy of cancer (01-06-2022)“…BackgroundDespite the preclinical promise of CD40 and 4-1BB as immuno-oncology targets, clinical efforts evaluating CD40 and 4-1BB agonists as monotherapy have…”
Get full text
Journal Article -
9
Transcriptome and proteome profiling of neural stem cells from the human subventricular zone in Parkinson's disease
Published in Acta neuropathologica communications (03-06-2019)“…It is currently accepted that the human brain has a limited neurogenic capacity and an impaired regenerative potential. We have previously shown the existence…”
Get full text
Journal Article -
10
TLR-Induced IL-12 and CCL2 Production by Myeloid Cells Is Dependent on Adenosine A3 Receptor–Mediated Signaling
Published in The Journal of immunology (1950) (15-04-2019)“…Abstract TLR-induced signaling potently activates cells of the innate immune system and is subject to regulation at different levels. Inflammatory conditions…”
Get full text
Journal Article -
11
Systematic study of tissue factor expression in solid tumors
Published in Cancer reports (01-02-2023)“…Background Elevated tissue factor (TF) expression, although restricted in normal tissue, has been reported in multiple solid cancers, and expression has been…”
Get full text
Journal Article -
12
Mechanistic and pharmacodynamic studies of DuoBody-CD3x5T4 in preclinical tumor models
Published in Life science alliance (01-11-2022)“…CD3 bispecific antibodies (bsAbs) show great promise as anticancer therapeutics. Here, we show in-depth mechanistic studies of a CD3 bsAb in solid cancer,…”
Get full text
Journal Article -
13
Alternative methods for the use of non-human primates in biomedical research
Published in ALTEX, alternatives to animal experimentation (2014)“…The experimental use of non-human primates (NHP) in Europe is tightly regulated and is only permitted when there are no alternatives available. As a result,…”
Get full text
Journal Article -
14
561 DuoBody®-PD-L1×4–1BB (GEN1046) induces superior immune-cell activation, cytokine production and cytotoxicity by combining PD-L1 blockade with conditional 4–1BB co-stimulation
Published in Journal for immunotherapy of cancer (01-11-2020)“…BackgroundCheckpoint inhibitors targeting the PD-1/PD-L1 axis (CPI) have changed the treatment paradigm and prognosis for patients with advanced solid tumors;…”
Get full text
Journal Article -
15
ATP-induced IL-1β secretion is selectively impaired in microglia as compared to hematopoietic macrophages
Published in Glia (01-12-2016)“…Under stressful conditions nucleotides are released from dying cells into the extracellular space, where they can bind to purinergic P2X and P2Y receptors…”
Get full text
Journal Article -
16
Expression of IL-1β in rhesus EAE and MS lesions is mainly induced in the CNS itself
Published in Journal of neuroinflammation (06-06-2016)“…Interleukin (IL)-1β is a pro-inflammatory cytokine that plays a role in the pathogenesis of multiple sclerosis (MS) and experimental autoimmune…”
Get full text
Journal Article -
17
Abstract 1846: DuoBody-CD40×4-1BB (GEN1042) induces dendritic-cell maturation and enhances T-cell activation and effector functions in vitro by conditional CD40 and 4-1BB agonist activity
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Abstract The clinical success of immune checkpoint inhibitor monoclonal antibodies (mAbs) has demonstrated potential for re-activation of anti-tumor immunity…”
Get full text
Journal Article -
18
ATP-induced IL-1[beta] secretion is selectively impaired in microglia as compared to hematopoietic macrophages
Published in Glia (01-12-2016)“…Under stressful conditions nucleotides are released from dying cells into the extracellular space, where they can bind to purinergic P2X and P2Y receptors…”
Get full text
Journal Article -
19
ATP-induced IL-1β secretion is selectively impaired in microglia as compared to hematopoietic macrophages: Microglial Adaptation of Innate Immune Responses
Published in Glia (01-12-2016)Get full text
Journal Article -
20
1208 DuoBody®-PD-L1x4–1BB (GEN1046) reverses T-cell exhaustion in vitro
Published in Journal for immunotherapy of cancer (01-11-2022)“…BackgroundDuoBody®-PD-L1x4-1BB (GEN1046) is an investigational, potential first-in-class bispecific immunomodulatory antibody designed to elicit an anti-tumor…”
Get full text
Journal Article